Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis-Reference-Cited by-同舟云学术

Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis

Published:2019-08-09 Issue:10 Volume:22 Page:1063-1072
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Laskier Vicki¹,Guy Holly¹,Fisher Mark¹,Neuman W. Richey²,Bucior Iwona²,Cohen Alexander T.³,Ren Shijie⁴

Affiliation:

1. Health Economics, FIECON Ltd, St Albans, UK;

2. Medical Affairs, Portola Pharmaceuticals, Inc, South San Francisco, CA, USA;

3. Department of Haematological Medicine, Guy’s and St. Thomas’ Hospitals, King’s College London, London, UK;

4. HEDS, ScHARR, The University of Sheffield, Sheffield, UK

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1645679

Reference56 articles.

1. Venous thromboembolic events in hospitalised medical patients

2. Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the US.

3. The epidemiology of venous thromboembolism

4. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Provider perceptions of extended venous thromboembolism prophylaxis for hospitalized medically ill patients;Thrombosis Update;2021

2. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine;Thrombosis and Haemostasis;2020-09-13